These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 16103206)
1. Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation. Kobayashi M; Igarashi H; Takeda A; Kato M; Matano T J Virol; 2005 Sep; 79(17):11529-32. PubMed ID: 16103206 [TBL] [Abstract][Full Text] [Related]
2. Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques. Kawada M; Igarashi H; Takeda A; Tsukamoto T; Yamamoto H; Dohki S; Takiguchi M; Matano T J Virol; 2006 Feb; 80(4):1949-58. PubMed ID: 16439550 [TBL] [Abstract][Full Text] [Related]
3. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Friedrich TC; Dodds EJ; Yant LJ; Vojnov L; Rudersdorf R; Cullen C; Evans DT; Desrosiers RC; Mothé BR; Sidney J; Sette A; Kunstman K; Wolinsky S; Piatak M; Lifson J; Hughes AL; Wilson N; O'Connor DH; Watkins DI Nat Med; 2004 Mar; 10(3):275-81. PubMed ID: 14966520 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial. Matano T; Kobayashi M; Igarashi H; Takeda A; Nakamura H; Kano M; Sugimoto C; Mori K; Iida A; Hirata T; Hasegawa M; Yuasa T; Miyazawa M; Takahashi Y; Yasunami M; Kimura A; O'Connor DH; Watkins DI; Nagai Y J Exp Med; 2004 Jun; 199(12):1709-18. PubMed ID: 15210746 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag. Chen ZW; Shen L; Miller MD; Ghim SH; Hughes AL; Letvin NL J Immunol; 1992 Dec; 149(12):4060-6. PubMed ID: 1460291 [TBL] [Abstract][Full Text] [Related]
6. In vivo fitness costs of different Gag CD8 T-cell escape mutant simian-human immunodeficiency viruses for macaques. Loh L; Batten CJ; Petravic J; Davenport MP; Kent SJ J Virol; 2007 May; 81(10):5418-22. PubMed ID: 17344299 [TBL] [Abstract][Full Text] [Related]
8. Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge. Mortara L; Letourneur F; Villefroy P; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I Virology; 2000 Dec; 278(2):551-61. PubMed ID: 11118377 [TBL] [Abstract][Full Text] [Related]
9. Use of molecular beacons for rapid, real-time, quantitative monitoring of cytotoxic T-lymphocyte epitope mutations in simian immunodeficiency virus. Peyerl FW; Barouch DH; Bazick HS; Manuel E; Letvin NL J Clin Microbiol; 2005 Sep; 43(9):4773-9. PubMed ID: 16145140 [TBL] [Abstract][Full Text] [Related]
10. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Allen TM; O'Connor DH; Jing P; Dzuris JL; Mothé BR; Vogel TU; Dunphy E; Liebl ME; Emerson C; Wilson N; Kunstman KJ; Wang X; Allison DB; Hughes AL; Desrosiers RC; Altman JD; Wolinsky SM; Sette A; Watkins DI Nature; 2000 Sep; 407(6802):386-90. PubMed ID: 11014195 [TBL] [Abstract][Full Text] [Related]
11. Differential patterns of immune escape at Tat-specific cytotoxic T cell epitopes in pigtail macaques. Mason RD; De Rose R; Kent SJ Virology; 2009 Jun; 388(2):315-23. PubMed ID: 19394064 [TBL] [Abstract][Full Text] [Related]
12. Abrogation of AIDS vaccine-induced cytotoxic T-lymphocyte efficacy in vivo due to a change in viral epitope flanking sequences. Moriya C; Igarashi H; Takeda A; Tsukamoto T; Kawada M; Yamamoto H; Inoue M; Iida A; Shu T; Hasegawa M; Nagai Y; Matano T Microbes Infect; 2008 Mar; 10(3):285-92. PubMed ID: 18316225 [TBL] [Abstract][Full Text] [Related]
13. Rates of HIV immune escape and reversion: implications for vaccination. Davenport MP; Loh L; Petravic J; Kent SJ Trends Microbiol; 2008 Dec; 16(12):561-6. PubMed ID: 18964018 [TBL] [Abstract][Full Text] [Related]